BRCA1 regulates the G2/M checkpoint by activating Chk1 kinase upon DNA damage

被引:390
|
作者
Yarden, RI
Pardo-Reoyo, S
Sgagias, M
Cowan, KH
Brody, LC [1 ]
机构
[1] NHGRI, Genome Technol Branch, NIH, Bethesda, MD 20892 USA
[2] Univ Nebraska, Med Ctr, Eppley Inst Res Canc, Omaha, NE 68198 USA
关键词
D O I
10.1038/ng837
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
The breast cancer tumor-suppressor gene, BRCA1, encodes a protein with a BRCT domain-a motif that is found in many proteins that are implicated in DNA damage response and in genome stability(1). Phosphorylation of BRCA1 by the DNA damage-response proteins ATM, ATR and hCds1/Chk2 changes in response to DNA damage and at replication-block checkpoints(2-5). Although cells that lack BRCA1 have an abnormal response to DNA damage, the exact role of BRCA1 in this process has remained unclear. Here we show that BRCA1 is essential for activating the Chk1 kinase that regulates DNA damage-induced G2/M arrest. Thus, BRCA1 controls the expression, phosphorylation and cellular localization of Cdc25C and Cdc2/cyclin B kinase-proteins that are crucial for the G2/M transition. We show that BRCA1 regulates the expression of both Wee1 kinase, an inhibitor of Cdc2/cyclin B kinase, and the 14-3-3 family of proteins that sequesters phosphorylated Cdc25C and Cdc2/cyclin B kinase in the cytoplasm(6). We conclude that BRCA1 regulates key effectors that control the G2/M checkpoint and is therefore involved in regulating the onset of mitosis.
引用
收藏
页码:285 / 289
页数:5
相关论文
共 50 条
  • [41] Phosphorylation of Minichromosome Maintenance 3 (MCM3) by Checkpoint Kinase 1 (Chk1) Negatively Regulates DNA Replication and Checkpoint Activation
    Han, Xiangzi
    Pozo, Franklin Mayca
    Wisotsky, Jacob N.
    Wang, Benlian
    Jacobberger, James W.
    Zhang, Youwei
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2015, 290 (19) : 12370 - 12378
  • [42] The Drosophila Grp/Chk1 DNA damage checkpoint controls entry into anaphase
    Royou, A
    Macias, H
    Sullivan, W
    CURRENT BIOLOGY, 2005, 15 (04) : 334 - 339
  • [43] DNA damage-induced S phase arrest in human breast cancer depends on Chk1, but G2 arrest can occur independently of Chk1, Chk2 or MAPKAPK2
    Zhang, Wen-Hui
    Poh, Alisa
    Fanous, Andrew A.
    Eastman, Alan
    CELL CYCLE, 2008, 7 (11) : 1668 - 1677
  • [44] Enhance the Efficacy of Doxorubicin Destabilizing the G2/M Checkpoint with a CHK1/CHK2 Inhibitor Pre-Treatment on Acute Lymphoblastic Leukemia
    di Rora', Andrea Ghelli Luserna
    Ferrari, Anna
    Imbrogno, Enrica
    Robustelli, Valentina
    Papayannidis, Cristina
    Abbenante, Maria Chiara
    Marconi, Giovanni
    Cavo, Michele
    Martinelli, Giovanni
    BLOOD, 2017, 130
  • [45] A DNA-Damage Selective Role for BRCA1 E3 Ligase in Claspin Ubiquitylation, CHK1 Activation, and DNA Repair
    Sato, Ko
    Sundaramoorthy, Elayanambi
    Rajendra, Eeson
    Hattori, Hiroyoshi
    Jeyasekharan, Anand D.
    Ayoub, Nabieh
    Schiess, Ralph
    Aebersold, Ruedi
    Nishikawa, Hiroyuki
    Sedukhina, Anna S.
    Wada, Haruka
    Ohta, Tomohiko
    Venkitaraman, Ashok R.
    CURRENT BIOLOGY, 2012, 22 (18) : 1659 - 1666
  • [46] Chk1 is required for G2/M checkpoint response induced by the catalytic topoisomerase II inhibitor ICRF-193
    Robinson, Helen M. R.
    Bratlie-Thoresen, Sigrid
    Brown, Robert
    Gillespie, David A. F.
    CELL CYCLE, 2007, 6 (10) : 1265 - 1267
  • [47] DNA damage-induced S and G2/M cell cycle arrest requires mTORC2-dependent regulation of Chk1
    Selvarajah, Jogitha
    Elia, Androulla
    Carroll, Veronica A.
    Moumen, Abdeladim
    ONCOTARGET, 2015, 6 (01) : 427 - 440
  • [48] p73 induction after DNA damage is regulated by checkpoint kinases Chk1 and Chk2
    Urist, M
    Tanaka, T
    Poyurovsky, MV
    Prives, C
    GENES & DEVELOPMENT, 2004, 18 (24) : 3041 - 3054
  • [49] Inhibition of the checkpoint kinase Chk1 induces DNA damage and cell death in human Leukemia and Lymphoma cells
    Bryant, Christopher
    Scriven, Kirsten
    Massey, Andrew J.
    MOLECULAR CANCER, 2014, 13
  • [50] An indolocarbazole inhibitor of human checkpoint kinase (Chk1) abrogates cell cycle arrest caused by DNA damage
    Jackson, JR
    Gilmartin, A
    Imburgia, C
    Winkler, JD
    Marshall, LA
    Roshak, A
    CANCER RESEARCH, 2000, 60 (03) : 566 - 572